3 September 2021 - As Democrats design a way to use the government’s leverage to lower drug prices for seniors, they are facing the possibility that drug makers could try to make up their profits by hiking prices for private insurers instead.
Lawmakers in both the House and Senate are eyeing drug pricing reforms as part of a major legislative push to deliver on President Biden’s agenda this fall.